Basilea-Pfizer’s Cresemba Heads For Indian Debut
Executive Summary
Basilea’s Cresemba appears on course to a debut in India and partner Pfizer expects the novel antifungal to bolster its existing portfolio in the segment. Pricing of the product will be keenly watched.